NO20055490D0 - Risperidon monohydroklorid - Google Patents

Risperidon monohydroklorid

Info

Publication number: NO20055490D0
Authority: NO; Norway
Prior art keywords: risperidone; monohydrochloride; risperidone monohydrochloride
Prior art date: 2003-04-22

Application number

NO20055490A

Other languages

English (en)

Other versions

NO20055490L (no

Inventor

Jiri Bartl

Reinerus Gerardus Gieling

Original Assignee

Synthon Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-22

Filing date

2005-11-21

Publication date

2005-11-21

2005-11-21 Application filed by Synthon Bv filed Critical Synthon Bv

2005-11-21 Publication of NO20055490D0 publication Critical patent/NO20055490D0/no

2006-01-23 Publication of NO20055490L publication Critical patent/NO20055490L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20055490A 2003-04-22 2005-11-21 Risperidon monohydroklorid NO20055490L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US46436403P	2003-04-22	2003-04-22
PCT/EP2004/004129 WO2004094415A1 (en)	2003-04-22	2004-04-15	Risperidone monohydrochloride

Publications (2)

Publication Number	Publication Date
NO20055490D0 true NO20055490D0 (no)	2005-11-21
NO20055490L NO20055490L (no)	2006-01-23

Family

ID=33310877

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20055485A NO20055485L (no)	2003-04-22	2005-11-21	Vannloselige salter av risperidon
NO20055490A NO20055490L (no)	2003-04-22	2005-11-21	Risperidon monohydroklorid

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO20055485A NO20055485L (no)	2003-04-22	2005-11-21	Vannloselige salter av risperidon

Country Status (5)

Country	Link
US (2)	US20040266791A1 (no)
EP (2)	EP1615924A1 (no)
AR (2)	AR044054A1 (no)
NO (2)	NO20055485L (no)
WO (2)	WO2004094414A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050232995A1 (en)	2002-07-29	2005-10-20	Yam Nyomi V	Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1708790B1 (en) *	2003-12-02	2010-04-21	PharmaNeuroBoost N.V.	Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders
US7884096B2 (en) *	2003-12-02	2011-02-08	Pharmaneuroboost N.V.	Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1695973A1 (en) *	2005-02-24	2006-08-30	Neuro3D	Ocaperidone salt and pharmaceutical compositions containing the same
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
NZ597621A (en)	2007-05-25	2013-06-28	Tolmar Therapeutics Inc	Sustained delivery formulations of risperidone compounds
EP2405967B1 (en) *	2009-03-12	2020-09-23	Delpor, Inc.	Implantable device for long-term delivery of drugs
HUE066287T2 (hu)	2011-04-25	2024-07-28	Geneora Pharma Shijiazhuang Co Ltd	Nyújtott leadású mikroszféra risperidon készítmény
PL2702060T3 (pl)	2011-04-26	2016-06-30	Torrent Pharmaceuticals Ltd	Kwasowe addycyjne sole risperidonu i ich kompozycje farmaceutyczne
WO2014164754A1 (en)	2013-03-11	2014-10-09	Durect Corporation	Injectable controlled release composition comprising high viscosity liquid carrier
WO2016149561A1 (en) *	2015-03-17	2016-09-22	Oak Crest Institute Of Science	Subdermal implants for the sustained delivery of water-soluble drugs
TW202313047A (zh)	2021-09-21	2023-04-01	西班牙商禾霏藥品實驗室有限公司	抗精神病可注射儲積型組合物
CN119072314A (zh)	2022-05-18	2024-12-03	罗维实验室制药股份公司	用于利培酮与cyp2d6酶抑制剂联合治疗的缓释注射组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4335127A (en) *	1979-01-08	1982-06-15	Janssen Pharmaceutica, N.V.	Piperidinylalkyl quinazoline compounds, composition and method of use
US4342870A (en) *	1980-03-28	1982-08-03	Janssen Pharmaceutica N.V.	Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) *	1981-07-15	1984-04-17	Janssen Pharmaceutica N.V.	Bicyclic pyrimidin-5-one derivatives
US4485107A (en) *	1982-11-01	1984-11-27	Janssen Pharmaceutica N.V.	[[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4804663A (en) *	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) *	1988-11-07	1992-10-27	Janssen Pharmaceutica N.V.	3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
GB9008850D0 (en) *	1990-04-19	1990-06-13	Janssen Pharmaceutica Nv	Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
TW376319B (en) *	1993-04-28	1999-12-11	Janssen Pharmaceutica Nv	Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
US5453425A (en) *	1994-07-11	1995-09-26	Janssen Pharmaceutica N.V.	Risperidone oral formulation

2004
- 2004-04-15 WO PCT/EP2004/004128 patent/WO2004094414A1/en active Application Filing
- 2004-04-15 EP EP04727566A patent/EP1615924A1/en not_active Withdrawn
- 2004-04-15 EP EP04727562A patent/EP1615923A1/en not_active Withdrawn
- 2004-04-15 WO PCT/EP2004/004129 patent/WO2004094415A1/en active Application Filing
- 2004-04-16 US US10/825,684 patent/US20040266791A1/en not_active Abandoned
- 2004-04-16 US US10/825,683 patent/US20040266790A1/en not_active Abandoned
- 2004-04-22 AR ARP040101358A patent/AR044054A1/es not_active Application Discontinuation
- 2004-04-22 AR ARP040101359A patent/AR044055A1/es not_active Application Discontinuation
2005
- 2005-11-21 NO NO20055485A patent/NO20055485L/no not_active Application Discontinuation
- 2005-11-21 NO NO20055490A patent/NO20055490L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20040266790A1 (en)	2004-12-30
EP1615924A1 (en)	2006-01-18
AR044055A1 (es)	2005-08-24
WO2004094415A1 (en)	2004-11-04
WO2004094414A1 (en)	2004-11-04
NO20055485L (no)	2006-01-23
US20040266791A1 (en)	2004-12-30
NO20055485D0 (no)	2005-11-21
EP1615923A1 (en)	2006-01-18
NO20055490L (no)	2006-01-23
AR044054A1 (es)	2005-08-24

Publication	Publication Date	Title
CY2014018I2 (el)	2015-12-09	Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
ATE340782T1 (de)	2006-10-15	Piperidinbenzolsulfonamidderivate
ATE505471T1 (de)	2011-04-15	Azaindol-kinaseinhibitoren
ATE363383T1 (de)	2007-06-15	Schlingenware
DK1682493T3 (da)	2009-04-20	Amidoacetonitrilderivater
ATE352550T1 (de)	2007-02-15	Chinazolinderivate
ATE395345T1 (de)	2008-05-15	Imidazol-4-yl-ethynyl-pyridin-derivate
IS8364A (is)	2006-03-20	N-þíasól-2-ýl-bensamíð afleiður
DK1597007T3 (da)	2013-04-02	Borepatron
AT502792A5 (de)	2007-05-15	Düsenanpressvorrichtung
DE602004019555D1 (de)	2009-04-02	Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone
NO20055490D0 (no)	2005-11-21	Risperidon monohydroklorid
DK1706373T3 (da)	2010-01-18	Amidoacetonitrilderivater
ATA662003A (de)	2005-11-15	Trink-mundstück
IS8045A (is)	2005-09-26	Púrín-6-ón-afleiður
PT1678290T (pt)	2017-10-16	Resumo
ATE446959T1 (de)	2009-11-15	Chromenonindole
DE60322439D1 (de)	2008-09-04	Anschlussstück
DE502004007017D1 (de)	2008-06-19	Zwischenfestlegung
DE10355350A8 (de)	2006-11-09	Elektromodul
ATE406350T1 (de)	2008-09-15	Prolinylarylacetamide
DE10329218B4 (de)	2007-05-16	Hotflue
SE0302862L (sv)	2005-05-01	Zener-Zap Minne
ATA1802003A (de)	2005-12-15	Verbundhonring
DE10316511B4 (de)	2005-10-20	Teigportionierer

Legal Events

Date	Code	Title	Description
2007-11-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application